Correlation Between Suzhou Novoprotein and Shenzhen Bioeasy

Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Shenzhen Bioeasy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Shenzhen Bioeasy into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Shenzhen Bioeasy Biotechnology, you can compare the effects of market volatilities on Suzhou Novoprotein and Shenzhen Bioeasy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Shenzhen Bioeasy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Shenzhen Bioeasy.

Diversification Opportunities for Suzhou Novoprotein and Shenzhen Bioeasy

0.88

Correlation Coefficient

Suzhou Novoprotein  Shenzhen Bioeasy

Very poor diversification

The 3 months correlation between Suzhou and Shenzhen is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Shenzhen Bioeasy Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shenzhen Bioeasy Bio and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Shenzhen Bioeasy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shenzhen Bioeasy Bio has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Shenzhen Bioeasy go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Shenzhen Bioeasy

Assuming the 90 days trading horizon Suzhou Novoprotein is expected to generate 2.26 times less return on investment than Shenzhen Bioeasy. But when comparing it to its historical volatility, Suzhou Novoprotein Scientific is 1.58 times less risky than Shenzhen Bioeasy. It trades about 0.11 of its potential returns per unit of risk. Shenzhen Bioeasy Biotechnology is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  666.00  in Shenzhen Bioeasy Biotechnology on September 3, 2024 and sell it today you would earn a total of  322.00  from holding Shenzhen Bioeasy Biotechnology or generate 48.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Suzhou Novoprotein Scientific  vs.  Shenzhen Bioeasy Biotechnology

Suzhou Novoprotein

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Suzhou Novoprotein Scientific are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Suzhou Novoprotein sustained solid returns over the last few months and may actually be approaching a breakup point.

Shenzhen Bioeasy Bio

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Bioeasy Biotechnology are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Bioeasy sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Suzhou Novoprotein and Shenzhen Bioeasy

The main advantage of trading using opposite Suzhou Novoprotein and Shenzhen Bioeasy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Shenzhen Bioeasy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shenzhen Bioeasy will offset losses from the drop in Shenzhen Bioeasy's long position.

The idea behind Suzhou Novoprotein Scientific and Shenzhen Bioeasy Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.